Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
No more making other posters the subject,
I do not care if they are flippers, longs, bashers or pumpers.
No more making other posters the subject....period
Post will be deleted and I will ask iHub management
to ban anyone that does not get it.
Please keep in mind that this is a stock specific board and is limited to discussions relating to SLJB only. Any other ticker mentioned that has no relevance to SLJB will be deleted.
No O/T (off topic) during trading hours
Please use O/T to begin the post otherwise
If you need to chat take it to the Parking Lot
http://www.investorshub.com/boards/board.asp?board_id=37
Please refrain from posting messages from RB. If a post from RB has been posted and not yet deleted, don't respond to it.
No attacking others.
No profanity.
Please do not post in all caps, it is rude.
If posting any article relating to SLJB, please cut and paste the article along with the link - do not just post the link.
Open discussions both positive and negative are welcome providing the information posted isn't slanderous and can be backed up or is followed by an "imo".
If you find spam on the board and don't see it deleted, please feel free to "PM" one of the moderators since we can't possibly catch every post.
Be smarter then the animal you are dealing with....!
Yes I see that allinone, took an hour break and the children start the crap again.
most of you should be ashamed of yourselves.
Thank you, thought that would be nice. That poster just knows how to get a rise out of most. and caused a lot of disruption.
I also want to thank those that are being patient while this board becomes a true tool for investor awareness.
sublime, great post thanks for that and I would like
publicly thank you for help in moderating this board as a new assistant.
WOW, a must read....
No more making other posters the subject,
I do not care if they are flippers, longs, bashers or pumpers.
No more making other posters the subject....period
Post will be deleted and I will ask iHub management
to ban anyone that does not get it.
Please keep in mind that this is a stock specific board and is limited to discussions relating to SLJB only. Any other ticker mentioned that has no relevance to SLJB will be deleted.
No O/T (off topic) during trading hours
Please use O/T to begin the post otherwise
If you need to chat take it to the Parking Lot
http://www.investorshub.com/boards/board.asp?board_id=37
Please refrain from posting messages from RB. If a post from RB has been posted and not yet deleted, don't respond to it.
No attacking others.
No profanity.
Please do not post in all caps, it is rude.
If posting any article relating to SLJB, please cut and paste the article along with the link - do not just post the link.
Open discussions both positive and negative are welcome providing the information posted isn't slanderous and can be backed up or is followed by an "imo".
If you find spam on the board and don't see it deleted, please feel free to "PM" one of the moderators since we can't possibly catch every post.
ATTENTION
I have had enough...!
I am moderator here whether some like it or not.
No more making other posters the subject,
I do not care if they are flippers, longs, bashers or pumpers.
No more making other posters the subject....period
Post will be deleted and I will ask iHub management
to ban anyone that does not get it.
TIA and have a nice day.
Since SLJB is taken, SYEV .49
I am trying believe me...!
Agree 100% on that Susie.
Tell them why chip?
BSEG - Big Screen's 'The Mirror' Inks International Sales Deal
Wednesday August 16, 2:51 pm ET
HOLLYWOOD, Calif., Aug. 16 /PRNewswire-FirstCall/ -- Big Screen Entertainment (OTC: BSEG - News) is pleased to announce that they have signed a deal with Showcase Entertainment to internationally distribute their latest feature film "The Mirror," starring Kelly LeBrock ("Woman in Red," "Weird Science") and Thaao Penghlis ("Mission Impossible," "Days of Our Lives").
(Photo: http://www.newscom.com/cgi-bin/prnh/20060816/LAW070 )
"Showcase has been around for many years and has an excellent reputation," states Rosslyn Hornsby, VP of Marketing. "We are working closely with them to bring maximum exposure and sales to this wonderful film."
"Thaao's large fan base in particular is eagerly anticipating the film's release," said BSEG President David Zappone. "We were happy to see Thaao featured on the cover of "Soap Opera Digest" last week."
The Mirror is being entered into numerous film festivals over the next few months. The final cut of the movie will be ready for distribution in September. Visit www.themirrorfilm.com for more information.
ABOUT THE COMPANY:
Big Screen Entertainment Group (OTC: BSEG - News) is a full service entertainment company designed to develop, produce, purchase, exhibit and distribute products in all media formats, including motion pictures, television, music, publishing, video games and cell phone content.
BSEG currently has two films completed, two films in post-production, one film in pre-production and four films in development. Visit our website at www.bigscreenent.com for more information on these movies.
Forward-Looking Statements:
A number of statements contained in this press release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Act of 1995. These forward-looking statements involve a number of risks and uncertainties, including timely development, and market acceptance of products and technologies, competitive market conditions, successful integration of acquisitions and the ability to secure additional sources of financing. When used in this press release, words such as "could," "plan," "estimate," "expect," "intend," "may," "potential," "should," and similar expressions are forward looking statements. Although Big Screen Entertainment Group believes that the expectations reflected in these forward-looking statements are reasonable, such statements involve risks and uncertainties and no assurance can be given that actual results will be consistent with these forward-looking statements.
Big Screen Entertainment Group
David Zappone, 323-960-4014
zapponed@bigscreenent.com
http://www.bigscreenent.com
www.forgetaboutitthefilm.com
--------------------------------------------------------------------------------
Source: Big Screen Entertainment Group
FCCN - Franchise Capital Corporation Shareholders to Receive Share Dividend From Sale of Kokopelli Franchise Company, LLC
Wednesday August 16, 2:46 pm ET
SCOTTSDALE, AZ--(MARKET WIRE)--Aug 16, 2006 -- The Board of Directors of Franchise Capital Corporation (Other OTC:FCCN.PK - News) today announced that the company has entered into a purchase agreement with The Great American Food Chain (Other OTC:GAMN.PK - News) that includes a common stock dividend for shareholders of Franchise Capital Corporation in consideration for the sale of Franchise Capital Corporation's interest in Kokopelli Franchise Company, LLC.
Under the terms of the agreement, The Great American Food Chain will receive Franchise Capital Corporation's 90% interest in Kokopelli Franchise Company, LLC. In consideration of the receipt of the interest in Kokopelli, The Great American Food Chain will deliver of up to 720,629 shares of its restricted common stock to the shareholders of Franchise Capital Corporation and assume a note payable, which Franchise Capital carried related to the asset.
All Franchise Capital Corporation shareholders of record as of August 31, 2006, as listed with the company's transfer agent and registrar, Transfer Online, will be eligible for the stock dividend. Shares will be issued at a ratio of one Great American Food Chain share for every 100 shares held in Franchise Capital Corporation. Certificates are expected to be mailed to eligible shareholders within sixty days of the record date.
The Great American Food Chain, Inc., whose closing stock price as of August 15, 2006 was $.50 per share, is a restaurant holding company based out of Dallas, Texas specializing in the development and expansion of proven independent restaurant concepts into multi-unit locations through corporate owned stores, licensing, and franchising opportunities. In addition to the newly acquired Kokopelli Fresh Mexican Grill, The Great American Food Chain also owns Spikes Boneyard Grill and is finalizing a licensing agreement on a third concept.
The company has also entered into a letter of intent (LOI) with Javelin Advisory Group, Inc. Under the terms of the LOI, Javelin will provide several services for the company including the preparation of financial statements of Franchise Capital and all necessary SEC filings to bring the company current with its filings requirements, organize and oversee a shareholder meeting to withdraw Franchise Capital Corporation's BDC status, and commit to a minimum capitalization target for any merger that would be in line with Nasdaq small-cap requirements.
For more information about The Great American Food Chain, see http://www.thegreatamericanfoodchain.com.
Safe Harbor Statement: The statements in this release that relate to future plans, expectations, events, performance and the like are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and the Securities Exchange Act of 1934. Actual results or events could differ materially from those described in the forward-looking statements due to a variety of factors, including the lack of funding, inability to complete required SEC filings, and others set forth in the Company's report on Form 10-K/A for fiscal year 2005 filed with the Securities and Exchange Commission.
Contact:
CONTACT:
Gemini Financial Communications
A. Beyer
951-587-8072
PLMA - Palomar's Rapid Growth Continues - Awareness Campaign Begins
Wednesday August 16, 2:33 pm ET
CARLSBAD, Calif., Aug. 16 /PRNewswire-FirstCall/ -- Palomar Enterprises, Inc. (OTC Bulletin Board: PLMA - News), announces the filing of The Company's 10-QSB for the second quarter, 2006. Palomar ended the quarter in the best financial position since The Company's inception, posting total assets of $4,624,318.
The Company's growth has exceeded the performance of the common stock, trading under the symbol PLMA. The Officers of Palomar Enterprises have resolved to bring awareness to the investment community by hiring multiple Investor Relations Firms. Palomar has retained International Monetary Resources, Inc. in California and Empire Relations Group, Inc. in New York to bring exposure of The Company's growth to their investor groups from coast to coast. Brent Fouch, CFO stated: "Until now, Palomar's growth has gone virtually un-noticed. It is now time to let the investment community know about this great, little Company to invest in."
Palomar Enterprises will continue to take advantage of the slowing real estate market, by purchasing foreclosed and financially distressed properties at a discount to market, with the intent to liquidate at higher prices. Palomar is a Real Estate Brokerage Firm located in Carlsbad, California which employs several licensed agents involved with the listing and sale of residential properties as well as in-house mortgage loan services.
www.palomarenterprises.com
--------------------------------------------------------------------------------
Source: Palomar Enterprises, Inc.
Yes great idea..thank you for that, it will cut my PMs down.
LOL...OK U win.
nope not I...LOL
smartinvestor that is the 3rd time you posted that, once was enough tia
Read the board guidelines, look as I said from the get go...
I am not looking to win a popularity contest.
I want to be able to read DD, enough of the profanity and personal attacks...everyone
including you chip.
I checked, full moon was last week, I can only hope we close green today so everyone stops the personal attacks.
GNBT - Generex Biotechnology Granted New U.S. Drug Delivery Patent
Wednesday August 16, 1:00 pm ET
Patent Covers Broad Claims for the Delivery of Macromolecules via the Buccal Cavity of the Mouth
TORONTO--(MARKET WIRE)--Aug 16, 2006 -- Generex Biotechnology Corporation (NASDAQ:GNBT - News), the leader in metabolic diseases drug delivery through the inner lining of the mouth, announced today that the United States Patent and Trademark Office has granted the Company a new United States Patent entitled Methods of Administering and Enhancing Absorption of Pharmaceutical Agents. The patent covers broad claims for the delivery of macromolecules via the buccal cavity of the mouth.
The patent relates to the Company's proprietary methodologies for the production of safe and effective oral formulations for the delivery of macromolecular pharmaceutical agents into the human body via the buccal region of the mouth. The process involves the creation of a stable mixed micellar solution containing the pharmaceutical agent, absorption enhancers, and other excipients. When the solution is introduced to the buccal mucosa, the result is increased bioavailability of the active drug and more rapid onset of action.
"This important new patent will augment the protection of our proprietary RapidMist(TM) drug delivery technologies," said Rose Perri, Generex Chief Operating Officer, "and, by extension, our flagship product, Generex Oral-lyn(TM), an oral insulin spray product for the treatment of diabetes. In addition to insulin, this gives us broad intellectual property protection for the delivery of other agents via the buccal region of the mouth."
The Company currently holds an aggregate of 77 patents worldwide (20 of which are United States Patents) and has an aggregate of 50 patent applications pending in various jurisdictions.
About Generex
Generex is engaged in the research and development of drug delivery systems and technologies. Generex has developed proprietary platform technologies for the delivery of drugs into the human body through the oral cavity (with no deposit in the lungs). The Company's proprietary liquid formulations allow drugs typically administered by injection to be absorbed into the body by the lining of the inner mouth using the Company's proprietary RapidMist(TM) device. The Company's flagship product, oral insulin (Generex Oral-lyn(TM)), which is available for commercial sale in Ecuador for the treatment of patients with Type-1 and Type-2 diabetes, is in various stages of clinical trials around the world.
For more information, visit the Generex website at www.generex.com.
Safe Harbor Statement: This release and oral statements made from time to time by Generex representatives concerning the same subject matter may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by introductory words such as "expects," "plans," "intends," "believes," "will," "estimates," "forecasts," "projects" or words of similar meaning, and by the fact that they do not relate strictly to historical or current facts. Forward-looking statements frequently are used in discussing potential product applications, potential collaborations, product development activities, clinical studies, regulatory submissions and approvals, and similar operating matters. Many factors may cause actual results to differ from forward-looking statements, including inaccurate assumptions and a broad variety of risks and uncertainties, some of which are known and others of which are not. Known risks and uncertainties include those identified from time to time in the reports filed by Generex with the Securities and Exchange Commission, which should be considered together with any forward-looking statement. No forward-looking statement is a guarantee of future results or events, and one should avoid placing undue reliance on such statements. Generex cannot be sure when or if it will be permitted by regulatory agencies to undertake additional clinical trials or to commence any particular phase of clinical trials. Because of this, statements regarding the expected timing of clinical trials cannot be regarded as actual predictions of when Generex will obtain regulatory approval for any "phase" of clinical trials. Generex claims the protection of the safe harbor for forward-looking statements that is contained in the Private Securities Litigation Reform Act.
Contact:
Contacts:
Shayne Gilliatt
Generex Biotechnology Corporation
Phone: (800) 391-6755
or (416) 364-2551
Andrew Hellman
CEOcast, Inc.
Phone: (212) 732-4300
Dolores Naney
Rubenstein Public Relations
Phone: (212) 843-8018
Email Contact
--------------------------------------------------------------------------------
Source: Generex Biotechnology
CPD - Caraco Pharmaceutical Laboratories Ltd. Announces FDA Approval to Market Baclofen
Wednesday August 16, 12:12 pm ET
DETROIT, Aug. 16 /PRNewswire-FirstCall/ -- Caraco Pharmaceutical Laboratories, Ltd., (Amex: CPD - News) announced today that the US Food and Drug Administration (FDA) has granted final approval for the Company's Abbreviated New Drug Application (ANDA) for Baclofen Tablets.
Caraco's Baclofen Tablet is a muscle relaxant and antispastic. It is useful for the alleviation of signs and symptoms of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity. Caraco has two strengths available, 10 mg and 20 mg tablets.
Daniel H. Movens, Caraco's Chief Executive Officer, said, "We are pleased the FDA granted us another swift approval during this quarter, adding value to our portfolio of products we market in the U.S. This approval marks the third approval in the current quarter, two within the last 30 days. We continue to work towards expanding our product line as quickly and effectively as possible adding measurable value as we go. We plan to launch this product to the market immediately." This approval brings our total marketed product selection to 23 different products represented by 49 strengths," he added.
Detroit-based Caraco Pharmaceutical Laboratories, Ltd., develops, manufactures and distributes generic and private-label prescription pharmaceuticals to the nation's wholesalers, distributors, drugstore chains and managed care providers.
Safe Harbor: This news release contains forward-looking statements made pursuant to the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are based on management's current expectations and are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward- looking statements. These risks and uncertainties are contained in the Corporation's filings with the Securities and Exchange Commission and include: information is of a preliminary nature and may be subject to adjustment, not obtaining or delays in obtaining FDA approval for new products, governmental restrictions on the sale of certain products, dependence on key personnel, development by competitors of new or superior products or cheaper products or new technology for the production of products, the entry into the market of new competitors, market and customer acceptance and demand for new pharmaceutical products, availability of raw materials, timing and success of product development and launches, integrity and reliability of the Corporation's data, lack of success of attaining full compliance with regard to regulatory and cGMP compliance, experiencing difficulty in managing our recent rapid growth and anticipated future growth, dependence on limited customer base, occasional credits to certain customers reflecting price reductions on products previously sold to them and still available as shelf- stock, possibility of an incorrect estimate of charge-backs and the impact of such an incorrect estimate on net sales, gross profit and net income, dependence on few products generating majority of sales, product liability claims for which the Company may be inadequately insured, subjectivity in judgment of management in applying certain significant accounting policies derived based on historical experience, terms of contracts, our observations of trends of industry, information received from our customers and other sources, to estimate revenues, accounts receivable allowances including chargebacks, rebates, income taxes, values of assets and inventories, litigation involving claims of patent infringement, litigation involving claims for royalties relating to a prior contract for one product and other risks identified in this report and identified from time to time in our reports and registration statements filed with the Securities and Exchange Commission. These forward-looking statements represent our judgment as of the date of this report. We disclaim, however, any intent or obligation to update our forward-looking statements.
--------------------------------------------------------------------------------
Source: Caraco Pharmaceutical Laboratories, Ltd.
AQWT - Third Aquacell Arsenic Removal System Begins Operation
Wednesday August 16, 11:42 am ET
Arsenic Removal System at Emerald Well Site Goes On Line
RANCHO CUCAMONGA, CA--(MARKET WIRE)--Aug 16, 2006 -- Aquacell Water (OTC BB:AQWT.OB - News) announced today that the arsenic removal system it built and installed at the Emerald well site has been given authorization to begin operating by the Arizona Department of Environmental Quality. The system uses ADSORBSIA(TM) GTO(TM) titanium-based arsenic removal media from The Dow® Chemical Company.
Karen Laustsen, President of Aquacell Water, said, "This is the third of our arsenic removal systems to be authorized to go on line in Arizona within the past week for the Cold Water Canyon Water Company. These three wells provide up to185 million gallons of water annually to Cold Water Canyon's customers."
Aquacell designs its arsenic removal systems to allow providers of drinking water to come into compliance with new federal EPA regulations that lower the maximum level of arsenic in drinking water from 50 parts-per-billion to 10 parts-per billion.
Aquacell Water, an authorized distributor of ADSORBSIA media in the southwest United States, selected this media for arsenic removal because of its inherent benefits that allow Aquacell to engineer and build smaller footprint systems with no wastewater discharge. Given the ability of ADSORBSIA arsenic removal media to operate under a wide variety of water conditions -- including pH fluctuations and resistance to other water contaminants that can affect competitors' medias and resins -- Aquacell is able to supply drinking water providers with a truly turnkey arsenic removal system that has both low capital and low operating costs.
About Aquacell Water Inc.
Aquacell Water, Inc., headquartered in Rancho Cucamonga, CA, manufactures in Tempe, Arizona, custom-designed turnkey water filtration and purification systems for municipal, industrial, commercial, and institutional applications around the world. The Company specializes in arsenic removal systems in association with media manufactured by The Dow Chemical Company. Aquacell's services include evaluation, design, engineering, manufacturing, installation, training and service.
For more information about Aquacell, visit www.aquacellwater.com.
Contact:
Contact:
Karen Laustsen
(909) 987-0456
--------------------------------------------------------------------------------
Source: Aquacell Water, Inc.
IVHG - Innova Holdings, Provider of Robotics Solutions for Military, Space and Homeland Security, Joins HomelandDefenseStocks.com
Wednesday August 16, 12:01 pm ET
Innovative Technology Improves the Functionality and Viability of Unmanned Robotic Vehicles for Military, Government, Homeland Security, First Responders, Law Enforcement, and Civilian Markets
POINT ROBERTS, WA and DELTA, BC--(MARKET WIRE)--Aug 16, 2006 -- www.HomelandDefenseStocks.com (HDS) and www.BorderandPortSecurity.com (BPS), global investor and industry news portals for the homeland defense and security sector, announces Innova Holdings, Inc. (OTC BB:IVHG.OB - News) as a new featured company. Innova Holdings has a deep robotics technology portfolio that has enabled them, through their subsidiaries, to target a variety of segments within the security arena to include the military, homeland security as well as the first responder and law enforcement markets such as fire, police and sheriffs' departments.
The use of robotics for homeland security and defense continues to grow as innovative technology has improved the functionality and viability of Unmanned Robotic Vehicles (URV) for search and rescue efforts, surveillance, explosives countermeasures and fire detection, etc. Recent validation for the Company's products and focus was realized through the acceptance, by former United States Attorney General John Ashcroft, to become Chairman of the Company's Board of Advisors. In addition, Innova Holdings has retained The Ashcroft Group, LLC to assist in building strategic relationships within the military, homeland security, first responder markets as well as the intelligence community.
Innova Holdings, through its subsidiaries Innova Robotics, Robotic Workspace Technologies and Coroware, continues to develop technology and applications for unmanned vehicles that utilize robotic devices to improve functionality. Robotic Workspace Technologies (RWT(TM)) recently launched its third generation, high-performance open architecture PC robotic control system. The Universal Robot Controller 3(TM) (URC3(TM)) handles physical/robot control over the operations of the robotic device and has web-enabled communication capability and Ethernet connectivity that permits remote diagnostics and monitoring, data collection and distribution. Innova Holdings has been awarded three pioneer patents by the USPTO for its control technology. In addition, Innova Holdings recently announced a multiple unit order for the URC3(TM) from a custom fabricator of parts for the trucking industry.
RWT has also developed control system software called RobotScript®, a universal robot programming language based on Microsoft's .NET Framework that provides a natural language programming environment that is intuitive, and easy to use, according to the Company.
Innova Holding's Coroware subsidiary is a robotics integrator that develops mobile service robotics and Web-service application framework solutions in cooperation with Microsoft Corp. Innova Holdings plans to expand its ability to deliver robotic solutions, addressing the growing need for mobile service automated systems, by integrating Innova Holdings' robotics arm and patented controller systems with CoroWare's software development, systems integration and robotics testing capabilities.
Innova Robotics, an Innova Holdings company, has the exclusive worldwide rights to market and sell a full line of Mesa Robotics unmanned ground vehicles in all markets. Mesa's unmanned robotic ground vehicles Matilda and Marv, recently participated and performed well according to the Company, in the Response Robot Evaluation Exercise conducted by The National Institute of Standards and Technology (NIST).
In addition, key strategic development relationships with Embry Riddle Aeronautical University (ERAU) and the University of South Florida (USF) have been established, which the Company plans to capitalize upon to further accelerate and develop the use of Unmanned Robotic Vehicles in military and commercial applications.
www.HomelandDefenseStocks.com and www.BorderandPortSecurity.com, portals within the InvestorIdeas.com content umbrella, do not make recommendations, but offer unique free information portals to research news, articles, blogs, interviews and a growing list of participating public companies in the security industry.
Homeland Defense and Security Portals Sponsor: (HDS is compensated by Innova Holdings as disclosed in disclaimer)
Innova Holdings, Inc. (OTC BB:IVHG.OB - News) For More Info Please Visit: http://www.homelanddefensestocks.com/co/IVHG/
Additional Homeland Security Content:
HomelandDefenseStocks.com (HDS) provides a variety of global defense and security content through: The Defense Market Report, by James H. Smith, Homeland Defense Business Correspondent for MSNBC, CNN and the BBC; The Spade Defense Index with Scott Sacknoff, Mallon's Security Report by Mallon Associates and the HDS Blog all available at: http://www.homelanddefensestocks.com.
HDS also includes one of the most comprehensive free Homeland Security stock lists in the investment industry: www.HomelandDefenseStocks.com/Companies/HomelandDefense/Stock_List.asp
Disclaimer: Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/or the company and/or IR firm and is not the opinion of our web sites. The site is currently compensated by its "featured companies." Innova Holdings (OTC BB:IVHG.OB - News) Five thousand dollars per month, plus a one-time $5000 equivalent in 144 shares. www.InvestorIdeas.com/About/Disclaimer.asp
Contact:
For more information contact:
Dawn Van Zant
800.665.0411
Email Contact
Ann-Marie Fleming
866.725.2554
Email Contact
--------------------------------------------------------------------------------
Source: HomelandDefenseStocks.com, Innova Holdings
CHR - Uncollateralized US$250 Million Letter of Credit Facility Secured
Wednesday August 16, 12:11 pm ET
ZUG, Switzerland, Aug. 16, 2006 (PRIMEZONE) -- Converium has secured a US$250 million letter of credit facility from a leading European banking group, at market conditions and available to Converium Ltd with immediate effect.
The facility is uncollateralized. It will be used primarily to support third party claims related to the underwriting business.
Paolo De Martin, Chief Financial Officer, commented: ``Our ability to arrange this major uncollateralized facility testifies to the renewed strength of Converium's balance sheet. From a business perspective, the facility further enhances our competitive position as we prepare for the forthcoming year-end treaty renewals.''
Converium has made it a policy not to provide any quarterly or annual earnings guidance and it will not update any past outlooks for full-year earnings. It will, however, continue to provide investors with perspectives on its value drivers, certain financial guidance for the full year, its strategic initiatives and those factors critical to understanding its business and operating environment.
About Converium
Converium is an independent international multi-line reinsurer known for its innovation, professionalism and service. Today Converium employs about 600 people in 18 offices around the globe and is organized into four business segments: Standard Property & Casualty Reinsurance, Specialty Lines and Life & Health Reinsurance, which are based principally on ongoing global lines of business, as well as the Run-Off segment, which primarily comprises the business from Converium Reinsurance (North America) Inc., excluding the U.S. originated aviation business portfolio. Converium has a ``BBB+'' financial strength rating (outlook positive) from Standard & Poor's and a ``B++'' financial strength rating (outlook stable) from A.M. Best Company.
Important Disclaimer
This document contains forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. It contains forward-looking statements and information relating to the Company's financial condition, results of operations, business, strategy and plans, based on currently available information. These statements are often, but not always, made through the use of words or phrases such as ``seek to,'' ``expects,'' ``should continue,'' ``believes,'' ``anticipates,'' ``estimates'' and ``intends.'' The specific forward-looking statements cover, among other matters, the Company's internal review and related restatement, the reinsurance market, the Company's operating results, certain financial guidance, e.g. related to the tax rate of the Company, the reduction of North American net reserves, the acquisition costs ratio and the costs of the Corporate Center, the rating environment and the prospect for improving results and expense reductions. Such statements are inherently subject to certain risks and uncertainties. Actual future results and trends could differ materially from those set forth in such statements due to various factors. Such factors include the impact of our ratings downgrade or a further lowering or loss of one of our financial strength ratings; the impact of the restatement on our ratings and client relationships; uncertainties of assumptions used in our reserving process; risk associated with implementing our business strategies and our capital improvement measures and the run-off of our North American business; cyclicality of the reinsurance industry; the occurrence of natural and man-made catastrophic events with a frequency or severity exceeding our estimates; acts of terrorism and acts of war; changes in economic conditions, including interest and currency rate conditions that could affect our investment portfolio; actions of competitors, including industry consolidation and development of competing financial products; a decrease in the level of demand for our reinsurance or increased competition in our industries or markets; a loss of our key employees or executive officers without suitable replacements being recruited within a suitable period of time; our ability to address material weaknesses we have identified in our internal control environment; political risks in the countries in which we operate or in which we reinsure risks; the passage of additional legislation or the promulgation of new regulation in a jurisdiction in which we or our clients operate or where our subsidiaries are organized; the effect on us and the insurance industry as a result of the investigations being carried out by the US Securities and Exchange Commission, New York's Attorney General and other governmental authorities; changes in our investment results due to the changed composition of our invested assets or changes in our investment policy; failure of our retrocessional reinsurers to honor their obligations or changes in the credit worthiness of our reinsurers; our failure to prevail in any current or future arbitration or litigation; and extraordinary events affecting our clients, such as bankruptcies and liquidations, and other risks and uncertainties, including those detailed in the Company's filings with the U.S. Securities and Exchange Commission and the SWX Swiss Exchange. The Company does not assume any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.
http://www.converium.com
Contact:
Converium Holding AG
Esther Gerster, Head of Public Relations
+41 (0) 44 639 90 22
Fax: +41 (0) 44 639 70 22
esther.gerster@converium.com
Marco Circelli, Head of Investor Relations & Market Research
+41 (0) 44 639 91 31
Fax: +41 (0) 44 639 71 31
marco.circelli@converium.com
Mladen Tomic, Investor Relations Officer
+41 (0) 44 639 91 39
Fax: +41 (0) 44 639 71 39
mladen.tomic@converium.com
--------------------------------------------------------------------------------
Source: Converium Holding AG
LOL coy, I confess I want a pic also then.
ok back
have conferred
Rack, multiple meanings
Rack of ribs, as in BBQ (burger flipping) does compute...
Not sure what this rack is for and does not compute
Nice rack, sorry that does not compute, will have to check with robot for meaning
be right back
Another confession then
I have found a new technology that has the robotic ability to watch all of my 6 monitors and deal with it while I nap all day.
PARL - Parlux Sells Perry Ellis Rights
Wednesday August 16, 10:45 am ET
Parlux Agrees to Sell Perry Ellis Fragrance Rights to Victory International for Up to $140M
FORT LAUDERDALE, Fla. (AP) -- Fragrance and beauty products maker Parlux Fragrances Inc. said Wednesday it agreed to sell its rights to Perry Ellis fragrance to Victory International LLC for up to $140 million.
Victory will pay $120 million for the rights and $20 million for inventory. That includes a deposit of $1 million, $10 million for inventory at closing and up to $9 million on delivery. The $120 million will be paid in 60 equal monthly installments of $2 million, beginning 90 days after closing.
Parlux said it was selling the rights to focus on developing celebrity fragrance brands. It holds licenses for Paris Hilton fragrances and other products, along with licenses to make designer fragrances for Guess?, XOXO, and other brands.
Parlux shares fell 8 cents to $4.98 during morning trading on the Nasdaq. The stock has traded between $4.43 and $19.24 during the past 52 weeks.
lol, ok confession time.
I had found LFLW/SJLB back in Sept. last year.
It has been a great burger flipper (14 times) till recently,
now I am just accumulating.
So my confession is that by taking on the enormous job of dealing
with all the emotions of the iHub board is solely self serving.
It was my hopes I would be able to slow down the BS so I could easily
find the real DD.
there I said it, hope I am forgiven?.
MFYS - Medify Solutions Limited 'Pink Sheets-MFYS'-First Mobile Device Units Delivered
Wednesday August 16, 10:45 am ET
STAFFORD, ENGLAND--(MARKET WIRE)--Aug 16, 2006 -- Medify Solutions Limited (Other OTC:MFYS.PK - News) confirmed today that MedifyRemote mobile devices for NHS customers have been delivered to the first GP Surgery in Doncaster. This is the beginning of the delivery of MedifyRemote to the NHS.
So far, 20 units have been ordered and delivered for the first GP site out of the scheduled 2500.
What does this mean?
This first GP surgery is not only the first NHS surgery but also the first EMIS surgery and marks the beginning of the roll out. In simple terms the first allocation will mean in published revenue projections:
20 x $85 x 12 equals $20,400 (for ONE site, 20 MedifyRemote units at $85 per unit per month for 12 months).
There are approximately 500,000 healthcare professionals in the NHS.
Therefore in real terms the announcement means the start of 500 000 x $85 x 12 annual projected revenue in delivery equals $510m annually. However, assuming only a 10% uptake in year one this equates to $51m annually.
MedifyRemote is the ideal solution for healthcare professionals to help them provide better, more efficient, and more informed quality care to patients. Whether it's in a patient's home, at a hospital bedside, consulting room or ambulance, vital access to patient records is now instant, secure and highly efficient. The system allows for 'real time' access and hence updates and records can be produced automatically. MedifyRemote offers significant advantages in terms of efficiency and clinical governance as proven within the UK NHS and is non platform specific.
Contact: press@medifysolutions.com
Company website: www.medifysolutions.com
ENDS
This news release contains forward-looking statements that are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of such forward-looking statements. The words "estimate," "project," "intends," "expects," "believes," and similar expressions are intended to identify forward-looking statements. Such forward- looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbour" provisions of the Private Securities Litigation Reform Act of 1995. For a more complete description of these and other risk factors that may affect the future performance of Medify Solutions Limited, see "Risk Factors" in the Company's Annual Report on Form 10-KSB and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward- looking statements, which speak only as of the date made and the Company undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.
Contact:
Contacts:
Medify Solutions Limited
Jonathan Bryant
+44 (0) 845 034 4090
press@medifysolutions.com
http://www.medifysolutions.com
--------------------------------------------------------------------------------
Source: Medify Solutions
Hehee, I will I promise.
FPLF - First Pet Life to Bring Discount Pet Products to Its Members
Wednesday August 16, 10:47 am ET
DALLAS, Aug. 16 /PRNewswire-FirstCall/ -- First Pet Life, Inc. (Pink Sheets: FPLF - News) has inked partnership agreements with several major web-based pet care product suppliers to provide its growing membership with extraordinary discounts. Cooperative advertising/affiliate partnerships allow First Pet Life to offer the first health, services and supply one stop shop for pet owners. Through the savings members receive, the pet health insurance policies can virtually pay for itself.
Based on what pet owners are used to, namely to purchase all of their pet care products at the grocery stores or at a pet supply retailer, with First Pet Life, they don't miss a step with the brands of products they're used to buying, they just save time and money by gaining discounts and having them delivered to their front door. They also add the option of obtaining excellent pet health coverage and services to assist in the care of their pets, all essentially for free.
Over the coming weeks, First Pet Life, Inc. will launch its partnership products within its E-commerce pet store.
First Pet Life members get incredible 20-50% discounts on the pet products that they typically purchase on a monthly basis. This is a member exclusive discount program which is a win-win situation for First Pet Life members, product suppliers and insurance provider.
About First Pet Life, Inc.
First Pet Life is a pet industry marketing company that is positioning itself to offer many services, including pet health insurance, pet supplies, along with boarding and grooming services nationwide. First Pet Life has the backing of a pet insurance industry leader as well as the backing of pet product manufactures, which will lend in strengthening its market position. The comprehensive products and services offered are broad yet inexpensive for the typical pet owner. Additional information is available at www.firstpetlife.com .
Disclaimer:
Matters discussed in this press release are "forward-looking statements." Statements describing company objectives are forward looking. Company's plans are also forward-looking statements and are subject to certain risks and uncertainties, including the financial performance of the company and market evaluations of its stock, which could cause actual results to differ materially from those anticipated.
Contact:
First Pet Life, Inc.
214-202-8580
--------------------------------------------------------------------------------
Source: First Pet Life, Inc.
G'morning doll, just peeking in.
GAMN / FCCN -Great American Food Chain Acquires Kokopelli Franchise Company
Wednesday August 16, 10:30 am ET
DALLAS, Aug. 16, 2006 (PRIMEZONE) -- The Great American Food Chain, Inc. (Other OTC:GAMN.PK - News), a restaurant holding company and concept developer, announced today that it has completed the acquisition of 90% interest in the Kokopelli Franchise Company, LLC, owner of Kokopelli Fresh Mexican Grill concept, from Franchise Capital Corporation (Pink Sheets:FCCN), in exchange for 720,629 of common stock in GAMN. Under terms of the agreement, all shareholders of record of FCCN stock as of August 31, 2006 will receive a dividend of 1 share of restricted common stock in GAMN for every 100 shares held in common stock of FCCN.
GAMN's CEO Edward Sigmond was quoted as saying, ``We are very excited about the opportunity this acquisition gives The Great American Food Chain, Inc. We believe the Kokopelli Fresh Mexican Grill concept will be a major competitor in the quick service Mexican food market. An additional restaurant is scheduled to open in Livonia, a suburb of Detroit, Michigan, in September this year. Other locations are scheduled to open in Phoenix, AZ; Portland, OR; Reno, NV; Riverside, CA; Jacksonville, FL; and Charlotte, NC by the 4th quarter this year. Kokopelli Franchise Company is poised for expansion with over 70 franchises having been sold to date. By design, The Great American Food Chain has been conservative in its undertakings to date. This acquisition adds a tremendous concept to our portfolio and provides us with a presence in a vast number of markets.''
About The Great American Food Chain, Inc.
The Great American Food Chain, Inc. is a restaurant holding company specializing in the development and expansion of proven independent restaurant concepts into multi-unit locations through corporate owned stores, licensing, and franchising opportunities. The Great American Food Chain currently owns two concepts, Kokopelli Fresh Mexican Grill, and Spikes Boneyard Grill, and is finalizing a licensing agreement with a third concept. GAMN is located in Dallas, Texas. For more information about The Great American Food Chain, see http://www.thegreatamericanfoodchain.com. Information on our website is not part of this press release.
Forward-Looking Statements
Any statements in this press release about The Great American Food Chain's expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and are forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995 (the ``Act''). These statements are often, but not always, made through the use of words or phrases such as ``believe,'' ``will,'' ``expect,'' ``anticipate,'' ``estimate,'' ``intend,'' ``plan,'' ``forecast,'' ``could,'' and ``would.'' There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including: limited operating history, need for future capital, risks inherent in the development and commercialization of restaurant concepts, protection of the Company's intellectual property, and economic conditions generally. Additional information on potential factors that could affect results and other risks and uncertainties are detailed from time to time in the Company's periodic reports. The Great American Food Chain claims the protection of the safe harbor for forward-looking statements under the Act and assumes no obligation and expressly disclaims any duty to update any forward-looking statement to reflect events or circumstances after the date of this news release or to reflect the occurrence of subsequent events.
Contact:
The Great American Food Chain, Inc.
Edward Sigmond
(214) 880-0446
Esigmond@gamnfc.com
--------------------------------------------------------------------------------
Source: Great American Food Chain, Inc.
PIMCQ - Pacific Magtron International Wins Nevada Bankruptcy Court's Approval for Reorganization
Wednesday August 16, 9:15 am ET
NEW YORK--(BUSINESS WIRE)--Aug. 16, 2006--Pacific Magtron International Corp. (OTCBB: PMICQ - News):
-- Pacific Magtron Expects to Effect Merger with Operating
Bio-Herbaceutical Company on or before September 11, 2006 and
Distribute New Shares to All Pacific Magtron and Advanced
Communications Shareholders within 15 Days Thereafter
Advanced Communications Technologies, Inc. (OTCBB: ADVC - News) and its majority owned subsidiary Pacific Magtron International Corp. (OTCBB: PMICQ - News), jointly announced today following a July 26, 2006 hearing that the U.S. Bankruptcy Court for the District of Nevada confirmed the plans of reorganization for Pacific Magtron International and its wholly-owned subsidiary, LiveWarehouse, Inc.
On August 11, 2006 the Bankruptcy Court entered an order approving and confirming the plans which are expected to become effective on or before September 11, 2006.
The plans provide for full payment to LiveWarehouse's creditors holding valid claims, at least a 50% payout to Pacific Magtron International's unsecured creditors and the merger of Herborium, Inc. into Live Warehouse a wholly-owned subsidiary of Pacific Magtron International, with Herborium as the surviving entity. Herborium, Inc. is a privately-held New Jersey-based botanical therapeutics company that provides all-natural medicinal products targeting both consumers and healthcare professionals that seek alternative and complementary answers to disease treatment, management and prevention. Herborium's botanical therapeutics, supported by clinical experience and testing, seek to address healthcare problems that are not met satisfactorily by conventional pharmaceuticals. After the merger, Pacific Magtron International expects to change its name to Herborium Group, Inc.
The plans also provide for cancellation, on the merger date, of all previously outstanding common and preferred shares of Pacific Magtron International and the distribution of newly issued shares of common stock of Herborium Group Inc. to all former Pacific Magtron International shareholders of record as of August 11, 2006. Advanced Communications' interest in Pacific Magtron International will also be cancelled and newly issued shares of common stock of Herborium Group Inc. will be distributed as a special stock distribution directly to all Advanced Communications' shareholders of record as of August 11, 2006 as well as to two former Pacific Magtron International executives pursuant to the terms of a settlement agreement also approved by the Bankruptcy Court. For more information about the anticipated distribution of the common stock of Herborium Group Inc. and other terms of the plans of reorganization, including the relative proportion of the Herborium Group, Inc. shares to be held by the Advanced Communications shareholders, the former Pacific Magtron International shareholders and others, see the Current Report on Form 8-K of Pacific Magtron International filed with the SEC today. The Form 8-K also describes the terms of the settlement agreement with the former executives of Pacific Magtron International. The plans of reorganization and the settlement agreement are attached as exhibits to the Report. The SEC's website is located at www.sec.gov.
Wayne Danson, president and CEO of Advanced Communications, said, "Although it has taken some time to resolve the Pacific Magtron matter, we believe we have reached a successful conclusion to reposition our Pacific Magtron International investment into an opportunity for our shareholders to benefit from the Herborium Group Inc. stock ownership, as all Advanced Communications shareholders as of the record date will be receiving shares of Herborium Group Inc. stock as a special share distribution. I am also pleased that this plan provides a recovery to the Pacific Magtron shareholders via an equity stake in Herborium Group Inc, which we believe is a dynamic growth oriented company. Danson added, "We expect the Herborium merger to be completed on or before September 11, 2006 and the Herborium Group Inc. stock distribution to both Advanced Communication and Pacific Magtron International shareholders to occur within 15 days thereafter."
Additional details of the special Herborium Group Inc. stock distribution to all shareholders of Advanced Communications and Pacific Magtron International will be announced in future company communications.
About Advanced Communications Technologies
Advanced Communications is a New York-based company specializing in the technology after-market service and supply chain, known as reverse logistics. Its principal operating unit, Encompass Group Affiliates, acquires businesses that provide computer and electronic repair services, and end-of-lifecycle and asset distribution services. Encompass owns Cyber-Test, an electronic equipment repair company that provides repair and reverse logistics services to third-party warranty companies that service OEMs, national retailers and national office equipment dealers. Cyber-Test's services include advance exchange, depot repair, call center support, parts and warranty management, repair of fax machines, printers, scanners, laptops, monitors and multi-function units, including PDAs and digital cameras. For more information, visit Cyber-Test's website at http://www.equipfix.com.
This release and oral statements made from time to time by Advanced Communications' and Pacific Magtron International's representatives concerning the same subject matter may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by introductory words such as "expects," "anticipate," "plans," "should," "believes," "will," or words of similar meaning, and by the fact that they do not relate strictly to historical or current facts. Many factors may cause actual results to differ from forward-looking statements, including the ability of Pacific Magtron International to effectuate the plans and the ability of Pacific Magtron International and Herborium to consummate the merger, as well as inaccurate assumptions and a broad variety of risks and uncertainties, some of which are known and others of which are not. Known risks and uncertainties include those identified from time to time in the reports filed by Advanced Communications and Pacific Magtron International with the Securities and Exchange Commission, which should be considered together with any forward-looking statement. No forward-looking statement is a guarantee of future results or events, and one should avoid placing undue reliance on such statements.
Contact:
for Pacific Magtron International Corp.
Wayne I. Danson, 646-227-1600
--------------------------------------------------------------------------------
Source: Pacific Magtron International Corp.
ETIM - Eternal Image Announces a 4-for-1 Forward Split of Common Stock
Wednesday August 16, 9:45 am ET
FARMINGTON HILLS, MI--(MARKET WIRE)--Aug 16, 2006 -- Eternal Image, Inc. (Other OTC:ETIM.PK - News), a public company engaged in the design, manufacturing, and marketing of customized designer caskets and urns, today announced that the process for a forward split of its shares of its common stock is being completed. The anticipated effective date will be announced.
"We are pleased to be able to offer this opportunity to our shareholders," said Clint Mytych, CEO of Eternal Image. "This forward split increases liquidity for our common shares and increases shareholder value for our existing stockholders."
For more information about Eternal Image and/or its hospitality plans for the NFDA Show, call 888-6-CASKET. Information about the product line can be found at www.eternalimage.net.
"Safe Harbor" Statement Under the Private Securities Litigation Reform Act of 1995
Statements in this press release relating to plans, strategies, economic performance and trends, projections of results of specific activities or investments, and other statements that are not descriptions of historical facts may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.
Forward-looking information is inherently subject to risks and uncertainties, and actual results could differ materially from those currently anticipated due to a number of factors, which include but are not limited to, risk factors inherent in doing business. Forward-looking statements may be identified by terms such as "may," "will," "should," "could," "expects," "plans," "intends," "anticipates," "believes," "estimates," "predicts," "forecasts," "potential," or "continue," or similar terms or the negative of these terms. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. The company has no obligation to update these forward-looking statements.
Contact:
Investor Relations Contact:
Peter McGoldrick
Integrity IR Services
515/825-6516
integrityir@optonline.net
Media Relations Contact:
Robbie Tarpley Raffish
a.s.a.p.r.
410/430-9705;
Robbie@asapr.com
Jen Meyer
a.s.a.p.r.
201/391-1714
jen@asapr.com
--------------------------------------------------------------------------------
Source: Eternal Image, Inc.
QTCE - Quantech's New Friction-Free Marketing System Offers Endless Flexibility
Wednesday August 16, 9:31 am ET
LONDON, Aug. 16, 2006 (PRIMEZONE) -- Quantech Electronics Corp. (Other OTC:QTCE.PK - News), software developer for marketing communications, announced today that Quantech continues to develop its new friction-free marketing system, in view of the system's enormous commercial potential.
Quantech is expanding and refining its friction-free marketing system to meet the virtually endless demand for such a system by commercial websites of every kind. Quantech's new friction-free marketing system creates a conversation between seller and visitor in the framework that allows vendors to monitor how their messages and products are being received in real time.
``Quantech's new system gives it clients access to a real-time focus group that helps clients understand immediately which offerings work better, and allows them to shape new campaigns without the delay that is traditionally caused by the need to gather and analyze extensive data,'' explains Liat Matilsky, CEO of Quantech. ``Thanks to Quantech's systems, vendors not only can tune in to website visitors' opinions on their products and services in real time, the system also allows them to extract valuable behavior-based analytics to customize future offerings for these same customers at the same time.''
``As online commerce gradually takes over the shopping experience, especially for the younger age-group, Quantech believes that its new system offers enormous growth potential for websites and other online commerce portals,'' adds Matilsky. ``The flexibility of this system allows us to easily adapt it to a wide range of industries operating domestically or globally.''
About Quantech
Quantech Electronics Corp. is a web-based software development company based in the UK that offers development services focusing on web-based desktop communication tools, call center support tools, and development packages designed to enhance the effectiveness of web-based advertising and instant messaging. Quantech Electronics Corp. develops powerful, easy-to-use software that enhances the effectiveness and efficiency of its customers' online and offline businesses. Driven to provide comprehensive solution packages for their clients' entire online business needs, Quantech focuses on customized developments for medium to large businesses, as well as start-ups. Offering several unique technologies and forged notable strategic alliances, Quantech's rapid-response systems construct client infrastructure at competitive prices. The company's client base includes medium to large sized businesses, as well as start-ups.
Forward-Looking Statements
Certain statements in this news release may contain 'forward-looking' information within the meaning of the Federal securities laws. All statements, other than statements of fact, included in this release may include forward-looking statements that may involve risks and uncertainties. There can be no assurance that such statements will be accurate and actual results and future events could differ materially from those anticipated in such statements. The Company undertakes no obligation to update forward-looking statements to reflect subsequently occurring events or circumstances or to reflect unanticipated events or developments.
To contact Quantech or access more information, please visit our web site at http://www.quan-tech.co.uk.
Contact:
Quantech Electronics Corp.
Liat Matilsky
effect1@bezeqint.net
www.quan-tech.co.uk
--------------------------------------------------------------------------------
Source: Quantech Electronics Corp.